HFE C282Y is a risk factor for hepatic veno-occlusive disease (HVOD) and carbamyl-phosphate synthetase (CPS) polymorphisms may counteract its adverse effects.
Bone Marrow Transplant. 2005 April 18.
Sat, August 18, 2012 @ 1:27 PM
Sun, August 19, 2012 @ 5:54 AM
Tue, November 1, 2016 @ 6:04 AM
Wed, February 22, 2017 @ 11:40 AM
Your Email/URL (Optional):
Comment Guidelines: No HTML is allowed. Off-topic or inappropriate comments will be edited or deleted. Thanks.